Holen Sie sich die Stockscreener-App
85.29
0.90%
0.76
Schlusskurs vom Vortag:
$84.53
Offen:
$84.85
24-Stunden-Volumen:
682.63K
Relative Volume:
0.87
Marktkapitalisierung:
$11.51B
Einnahmen:
$2.48B
Nettoeinkommen (Verlust:
$91.51M
KGV:
42.43
EPS:
2.01
Netto-Cashflow:
$293.77M
1W Leistung:
+2.03%
1M Leistung:
+16.56%
6M Leistung:
+29.58%
1J Leistung:
+85.13%
1-Tages-Spanne:
$84.44
$85.74
1-Wochen-Bereich:
$83.08
$85.74
52-Wochen-Spanne:
$44.02
$85.74
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
85.29 | 11.51B | 2.48B | 91.51M | 293.77M | 2.01 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
GMED (Globus Medical) Operating Cash Flow per Share : $3.02 (TTM As of Sep. 2024) - GuruFocus.com
GMED (Globus Medical) Revenue : $2,479 Mil (TTM As of Sep. 2024) - GuruFocus.com
GMED (Globus Medical) Land And Improvements : $10 Mil (As of Sep. 2024) - GuruFocus.com
Swedbank AB Has $28.62 Million Stock Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Massachusetts Financial Services Co. MA Buys Shares of 369,102 Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Shares Acquired by Intech Investment Management LLC - MarketBeat
Globus Medical director David Davidar sells shares for $3.4 million By Investing.com - Investing.com Australia
Globus Medical's SWOT analysis: stock soars on merger synergies, FDA hurdles loom - Investing.com
Globus Medical CEO Scavilla sells $11.05 million in stock By Investing.com - Investing.com Australia
Globus Medical CEO Scavilla sells $11.05 million in stock - Investing.com
Globus Medical director David Davidar sells shares for $3.4 million - Investing.com
GMED (Globus Medical) Peter Lynch Fair Value : $28.96 (As of Nov. 25, 2024) - GuruFocus.com
GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub - Yahoo Finance
GMED (Globus Medical) Operating Income : $169 Mil (TTM As of Sep. 2024) - GuruFocus.com
Quest Partners LLC Invests $523,000 in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Eagle Asset Management Inc. Purchases 29,573 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives $88.18 Consensus PT from Analysts - MarketBeat
Globus Medical Launches ExcelsiusHub™ Navigation System - The Manila Times
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue? - MSN
Globus Medical stock soars to all-time high of $84.89 By Investing.com - Investing.com Canada
GMED (Globus Medical) 50-Day SMA : $74.46 (As of Nov. 22, 2024) - GuruFocus.com
Globus Medical stock soars to all-time high of $84.89 - Investing.com
Options Movement At Globus Medical: David Paul Exercises Worth $1.55M - Benzinga
Overlook Medical Center Adds ExcelsiusGPS™ Robotic Navigation System to Enhance Spine Surgeries - TAPinto.net
Overlook Medical Center adds ExcelsiusGPS™ robotic navigation system to enhance spine surgeries - TAPinto.net
Aurora Investment Counsel Lowers Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Orthopedic Anchor Market Overall Study Report 2024-2032 | - openPR
GMED (Globus Medical) LT-Debt-to-Total-Asset : 0.02 (As of Sep. 2024) - GuruFocus.com
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" - MSN
Globus Medical (MEX:GMED) Asset Turnover : 0.13 (As of Sep. 2024) - GuruFocus.com
Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? - MSN
Global Alpha Capital Management Ltd. Has $63.32 Million Holdings in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term - MSN
Segall Bryant & Hamill LLC Buys 26,047 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (NYSE:GMED) Downgraded by StockNews.com to Hold - MarketBeat
Globus Medical Boosts 2024 Outlook For Third Time, Stock Hits All-Time High - RTTNews
Thrivent Financial for Lutherans Sells 29,106 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical Stock: Re-Rated After A Solid Year (NYSE:GMED) - Seeking Alpha
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Vaughan Nelson Investment Management L.P. - MarketBeat
Principal Financial Group Inc. Decreases Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Janus Henderson Group PLC Adjusts Stake in Globus Medical Inc - GuruFocus.com
Expanding Global Market, NuVasive Benefits to Aid GMED Stock - MSN
Globus Medical's SWOT analysis: robotic surgery drives stock growth By Investing.com - Investing.com Nigeria
Globus Medical's SWOT analysis: robotic surgery drives stock growth - Investing.com
Globus Medical price target raised to $83 from $74 at Morgan Stanley - Yahoo Finance
Some May Be Optimistic About Globus Medical's (NYSE:GMED) Earnings - Yahoo Finance
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Canada Finance
Globus Medical, Inc. (NYSE:GMED) Shares Purchased by Lisanti Capital Growth LLC - MarketBeat
Globus Medical (NYSE:GMED) Price Target Raised to $83.00 - MarketBeat
Insider Selling: Globus Medical, Inc. (NYSE:GMED) SVP Sells 5,000 Shares of Stock - MarketBeat
Globus Medical, Inc. (NYSE:GMED) CEO Daniel T. Scavilla Sells 60,000 Shares - MarketBeat
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):